Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 5 Key Players companies in Psilocybin
by Highest Patent Value in the Canada in 2020

The Psilocybin top 5 is Discovery PatSnap’ annual ranking of the top 5 Highest Patent Value Psilocybin Key Players in the Canada. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2020, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Psilocybin (/ˌsaɪləˈsaɪbɪn/ sy-lə-SY-bin) is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms. The most potent are members of the genus Psilocybe, such as P. azurescens, P. semilanceata, and P. cyanescens, but psilocybin has also been isolated from about a dozen other genera. As a prodrug, psilocybin is quickly converted by the body to psilocin, which has mind-altering effects similar, in some aspects, to those of LSD, mescaline, and DMT. In general, the effects include euphoria, visual and mental hallucinations, changes in perception, a distorted sense of time, spiritual experiences, and can include possible adverse reactions such as nausea and panic attacks.
#
Company Name
Region
Tech Topics
Total
1
Psilo Scientific Ltd.
Drug discovery
Avg patent value: 60,980
2
Diamond Therapeutics
Psychedelic drug,Biology,Pharmacy and Therapeutics,
...[+2]
Avg patent value: 27,000
3
Diamond Therapeutics, Inc.
Psychedelic drug
Avg patent value: 27,000
4
Pike Therapeutics, Inc.
Botanical drug,Herb
Avg patent value: 15,000
5
Mydecine Innovations Group, Inc.
Crop,Pharmacy,Land development,
...[+1]
Avg patent value: 0
Page generation time: Jun 21 2025